9Jaruratanasirikul S,Sudsai T.Comparison of the pharmacodynamics of imipenem in patients with ventilator-associated pneumonia following administration by 2 or 0.5h infusion[J].J Antimicrob Chemother,2009,63(3):560-563.
4Grif K,Dierich MP,Pfaller K,et al.In vitro activity of fosfomycin in combination with various antistaphyloccal substances[J].J Antimicrob Chemother,2001,48 (2):209 -217.
5Kastoris AC,Rafailidis PI,Vouloumanou EK,et al.Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria[J].Eur J Clin Pharmacol,2010,66(4):359 -368.
6Clinical and Laboratory Standards Instiute (CLSI)/NCCLS[S].Performence stcmdards for antimicrobial susceptibility testing stamdards:nighteenth informational supplement,2009.M100-S19.
7Dohmen PM.Antibiotic resistance in common pathogens reinforces the need to minimize surgical site infections[J].J Hospital Infection,2008,70(2 ):15-20.
10Brazlerr DW,Houck PM.Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project[J].J Am Surgery,2005,189(3 ): 395 -404.
